Terms: = Liver cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR
470 results:
1. Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based car-T technology.
Lin K; Xia B; Wang X; He X; Zhou M; Lin Y; Qiao Y; Li R; Chen Q; Li Y; Feng J; Chen T; Chen C; Li X; Zhang H; Lu L; Liu B; Zhang X
J Transl Med; 2024 Apr; 22(1):349. PubMed ID: 38610029
[TBL] [Abstract] [Full Text] [Related]
2. Diindoles produced from commensal microbiota metabolites function as endogenous car/Nr1i3 ligands.
Liu J; Malekoltojari A; Asokakumar A; Chow V; Li L; Li H; Grimaldi M; Dang N; Campbell J; Barrett H; Sun J; Navarre W; Wilson D; Wang H; Mani S; Balaguer P; Anakk S; Peng H; Krause HM
Nat Commun; 2024 Mar; 15(1):2563. PubMed ID: 38519460
[TBL] [Abstract] [Full Text] [Related]
3. Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted car-T cell therapy: a case report.
Zhong G; Zhang X; Guo Z; Gao Y; Zhao B; Liu X; Chen L; Qiao J; Yu C; Wang L; Li Y; Yu L
Front Immunol; 2024; 15():1325860. PubMed ID: 38487523
[TBL] [Abstract] [Full Text] [Related]
4. Chimeric Antigen Receptor T Cell Therapy for Hepatocellular carcinoma: Where Do We Stand?
Aggeletopoulou I; Kalafateli M; Triantos C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473878
[TBL] [Abstract] [Full Text] [Related]
5. Direct and Indirect Chimeric Antigen Receptor T-Cell Imaging with PET/MRI in a Tumor Xenograft Model.
Kim SY; Soh H; Jung JH; Cho EH; Kim H; Ju JM; Sheen JH; Lee SJ; Oh SJ; Lee SJ; Chung J; Ryu JS
Radiology; 2024 Feb; 310(2):e231406. PubMed ID: 38411517
[TBL] [Abstract] [Full Text] [Related]
6. The TOPK Inhibitor HI-TOPK-032 Enhances car T-cell Therapy of Hepatocellular carcinoma by Upregulating Memory T Cells.
Zhang Q; Zheng F; Chen Y; Liang CL; Liu H; Qiu F; Liu Y; Huang H; Lu W; Dai Z
Cancer Immunol Res; 2024 May; 12(5):631-643. PubMed ID: 38407902
[TBL] [Abstract] [Full Text] [Related]
7. Mesothelin car T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.
Wehrli M; Guinn S; Birocchi F; Kuo A; Sun Y; Larson RC; Almazan AJ; Scarfò I; Bouffard AA; Bailey SR; Anekal PV; Montero Llopis P; Nieman LT; Song Y; Xu KH; Berger TR; Kann MC; Leick MB; Silva H; Salas-Benito D; Kienka T; Grauwet K; Armstrong TD; Zhang R; Zhu Q; Fu J; Schmidts A; Korell F; Jan M; Choi BD; Liss AS; Boland GM; Ting DT; Burkhart RA; Jenkins RW; Zheng L; Jaffee EM; Zimmerman JW; Maus MV
Clin Cancer Res; 2024 May; 30(9):1859-1877. PubMed ID: 38393682
[TBL] [Abstract] [Full Text] [Related]
8. Mno
Duan J; Zhao S; Duan Y; Sun D; Zhang G; Yu D; Lou Y; Liu H; Yang S; Liang X; Ma C; Liu H; Qiu J; Gao L; Sang Y
Adv Healthc Mater; 2024 Apr; 13(11):e2303963. PubMed ID: 38296248
[TBL] [Abstract] [Full Text] [Related]
9. γδ T Cells: A Game Changer in the Future of Hepatocellular carcinoma Immunotherapy.
Papadakos SP; Arvanitakis K; Stergiou IE; Koutsompina ML; Germanidis G; Theocharis S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338658
[TBL] [Abstract] [Full Text] [Related]
10. A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [
Trautwein NF; Schwenck J; Seitz C; Seith F; Calderón E; von Beschwitz S; Singer S; Reischl G; Handgretinger R; Schäfer J; Lang P; Pichler BJ; Schulte JH; la Fougère C; Dittmann H
Theranostics; 2024; 14(3):1212-1223. PubMed ID: 38323317
[No Abstract] [Full Text] [Related]
11. Recent Progress in Systemic Therapy for Advanced Hepatocellular carcinoma.
Sadagopan N; He AR
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279258
[TBL] [Abstract] [Full Text] [Related]
12. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
13.
Sun C; Li D; Wang Z
Immunotherapy; 2024 Mar; 16(5):331-340. PubMed ID: 38264838
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of Chelator-to-Antibody Ratio on Development of
Tsai SC; Farn SS; Lo WL; Ou Yang FY; Kang YC; Chen LC; Chen KT; Liao JW; Kung JY; Chen JT; Huang FJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138961
[No Abstract] [Full Text] [Related]
15. Interaction with YAP underlies the species differences between humans and rodents in car-dependent hepatocyte proliferation.
Shizu R; Makida N; Sobe K; Ishimura M; Takeshita A; Hosaka T; Kanno Y; Sasaki T; Yoshinari K
Toxicol Sci; 2024 Feb; 198(1):101-112. PubMed ID: 38128062
[TBL] [Abstract] [Full Text] [Related]
16. Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy.
Ghasemi A; Martinez-Usatorre A; Li L; Hicham M; Guichard A; Marcone R; Fournier N; Torchia B; Martinez Bedoya D; Davanture S; Fernández-Vaquero M; Fan C; Janzen J; Mohammadzadeh Y; Genolet R; Mansouri N; Wenes M; Migliorini D; Heikenwalder M; De Palma M
Nat Cancer; 2024 Feb; 5(2):240-261. PubMed ID: 37996514
[TBL] [Abstract] [Full Text] [Related]
17. Anatomical liver resection using the ultrasound-guided compression technique in minimal access surgery.
Procopio F; Branciforte B; Galvanin J; Costa G; Franchi E; Cimino M; Torzilli G
Surg Endosc; 2024 Jan; 38(1):193-201. PubMed ID: 37957299
[TBL] [Abstract] [Full Text] [Related]
18. Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling.
Bansal A; DeGrado TR; Pandey MK
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955388
[TBL] [Abstract] [Full Text] [Related]
19. STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells.
Bu Q; Deng Y; Wang Q; Deng R; Hu S; Pei Z; Zhang Y
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127575. PubMed ID: 37866563
[TBL] [Abstract] [Full Text] [Related]
20. GPC3-IL7-CCL19-car-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
[TBL] [Abstract] [Full Text] [Related]
[Next]
